Money · Lobbying reports · 119th Congress
S. 2658
27 saved lobbying reports name S. 2658.
27 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read November 22, 2026 at 12:39 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Filed | Report |
|---|---|---|---|---|---|
| BCBSM, INC. | BCBSM INC | $30,000.00reported as expenses | July to September 2026 | Open the report | |
| THE NICKLES GROUP, LLC | AMGEN | $60,000.00reported as income | July to September 2026 | Open the report | |
| VIATRIS INC. | VIATRIS INC | $450,000.00reported as expenses | July to September 2026 | Open the report | |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | $250,000.00reported as expenses | July to September 2026 | Open the report | |
| RADIUS ADVOCACY, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $30,000.00reported as income | July to September 2026 | Open the report | |
| RADIUS ADVOCACY, LLC | COUNCIL FOR INNOVATION PROMOTION (C4IP) | $50,000.00reported as income | July to September 2026 | Open the report | |
| AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | $3,010,000.00reported as expenses | July to September 2026 | Open the report | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $7,040,000.00reported as expenses | July to September 2026 | Open the report | |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | $1,530,000.00reported as expenses | July to September 2026 | Open the report | |
| COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | $340,000.00reported as income | July to September 2026 | Open the report | |
| AMGEN, INC. | AMGEN INC | $3,150,000.00reported as expenses | July to September 2026 | Open the report | |
| JOHNSON & JOHNSON SERVICES, INC. | JOHNSON & JOHNSON SERVICES INC | $2,220,000.00reported as expenses | July to September 2026 | Open the report | |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | SUN PHARMACEUTICAL INDUSTRIES, INC. | $140,000.00reported as expenses | July to September 2026 | Open the report | |
| BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | $120,000.00reported as expenses | July to September 2026 | Open the report | |
| FRESENIUS KABI USA LLC | FRESENIUS KABI USA LLC | $630,000.00reported as expenses | July to September 2026 | Open the report | |
| CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | $16,480,000.00reported as expenses | July to September 2026 | Open the report | |
| EISAI INC. | EISAI INC. | $450,000.00reported as expenses | July to September 2026 | Open the report | |
| TAKEDA PHARMACEUTICALS AMERICA, INC. | TAKEDA PHARMACEUTICALS AMERICA INC | $1,450,000.00reported as expenses | July to September 2026 | Open the report | |
| FIERCE GOVERNMENT RELATIONS | ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA) | $60,000.00reported as income | July to September 2026 | Open the report | |
| TIBER CREEK GROUP | TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) | $80,000.00reported as income | July to September 2026 | Open the report | |
| TRAVERE THERAPEUTICS | TRAVERE THERAPEUTICS | $100,000.00reported as expenses | July to September 2026 | Open the report | |
| TIBER CREEK GROUP | PHRMA | $110,000.00reported as income | July to September 2026 | Open the report | |
| TIBER CREEK GROUP | PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION | $50,000.00reported as income | July to September 2026 | Open the report | |
| CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $50,000.00reported as income | July to September 2026 | Open the report | |
| ASSOCIATION FOR ACCESSIBLE MEDICINES | ASSOCIATION FOR ACCESSIBLE MEDICINES | $770,000.00reported as expenses | July to September 2026 | Open the report | |
| S-3 GROUP | FRESENIUS KABI | $30,000.00reported as income | July to September 2026 | Open the report | |
| E3 STRATEGIC CONSULTING GROUP | PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION | $60,000.00reported as income | July to September 2026 | Open the report |